Literature DB >> 21686268

RhoGDI3 and RhoG: Vesicular trafficking and interactions with the Sec3 Exocyst subunit.

Annie Morin1, Fabrice P Cordelières, Jacqueline Cherfils, Birgitta Olofsson.   

Abstract

RhoGDIs are negative regulators of small GTP-binding proteins of the Rho family, which have essential cellular functions in most aspects of actin-based morphology and motility processes. They extract Rho proteins from membranes, keep them in inactive rhoGDI/Rho complexes and eventually deliver them again to specific membranes in response to cellular signals. RhoGDI3, the most divergent member of the rhoGDI family, is well suited to document the underlying molecular mechanisms, since the active and inactive forms of its cellular target, RhoG, have well-separated subcellular localizations. In this study, we investigate trafficking structures and molecular interactions involved in rhoGDI3-mediated shuttling of RhoG between the Golgi and the plasma membrane.Bimolecular fluorescence complementation and acceptor-photobleaching FRET experiments suggest that rhoGDI3 and RhoG form complexes on Golgi and vesicular structures in mammalian cells. 4D-videomicroscopy confirms this localization, and show that RhoG/rhoGDI3-labelled structures are less dynamic than RhoG and rhoGDI3-labeled vesicles, consistent with the inhibitory function of rhoGDI3. Next, we identify the Exocyst subunit Sec3 as a candidate rhoGDI3 partner in cells. RhoGDI3 relocates a subcomplex of the Exocyst (Sec3 and Sec8) from the cytoplasm to the Golgi, while Sec6 is unaffected. Remarkably, Sec3 increases the level of GTP-bound endogenous RhoG, the RhoG-dependent induction of membrane ruffles, and the formation of intercellular tunneling nanotube-like protrusions.Altogether, our study identifies a novel link between vesicular traffic and the regulation of Rho proteins by rhoGDIs. It also suggests that components of the Exocyst machinery may be involved in RhoG functions, possibly regulated by rhoGDI3.

Entities:  

Year:  2010        PMID: 21686268      PMCID: PMC3116606          DOI: 10.4161/sgtp.1.3.15112

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  63 in total

Review 1.  The exocyst complex in polarized exocytosis.

Authors:  Shu-Chan Hsu; Daniel TerBush; Mathew Abraham; Wei Guo
Journal:  Int Rev Cytol       Date:  2004

2.  RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG.

Authors:  G Zalcman; V Closson; J Camonis; N Honoré; M F Rousseau-Merck; A Tavitian; B Olofsson
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

3.  Activation of Rac1 by RhoG regulates cell migration.

Authors:  Hironori Katoh; Kiyo Hiramoto; Manabu Negishi
Journal:  J Cell Sci       Date:  2005-12-08       Impact factor: 5.285

4.  Visualization and quantification of vesicle trafficking on a three-dimensional cytoskeleton network in living cells.

Authors:  Victor Racine; Martin Sachse; Jean Salamero; Vincent Fraisier; Alain Trubuil; Jean-Baptiste Sibarita
Journal:  J Microsc       Date:  2007-03       Impact factor: 1.758

5.  Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.

Authors:  Y Wu; K McRoberts; S S Berr; H F Frierson; M Conaway; D Theodorescu
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 9.867

6.  Dissociation of Rac1(GDP).RhoGDI complexes by the cooperative action of anionic liposomes containing phosphatidylinositol 3,4,5-trisphosphate, Rac guanine nucleotide exchange factor, and GTP.

Authors:  Yelena Ugolev; Yevgeny Berdichevsky; Carolyn Weinbaum; Edgar Pick
Journal:  J Biol Chem       Date:  2008-05-27       Impact factor: 5.157

Review 7.  The exocyst complex in polarized exocytosis.

Authors:  Bing He; Wei Guo
Journal:  Curr Opin Cell Biol       Date:  2009-05-25       Impact factor: 8.382

Review 8.  Rho GTPases in cancer cell biology.

Authors:  Francisco M Vega; Anne J Ridley
Journal:  FEBS Lett       Date:  2008-05-05       Impact factor: 4.124

9.  Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers.

Authors:  Wen G Jiang; Gareth Watkins; Jane Lane; Giles H Cunnick; Anthony Douglas-Jones; Kefah Mokbel; Robert E Mansel
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

10.  RhoG regulates endothelial apical cup assembly downstream from ICAM1 engagement and is involved in leukocyte trans-endothelial migration.

Authors:  Jaap D van Buul; Michael J Allingham; Thomas Samson; Julia Meller; Etienne Boulter; Rafael García-Mata; Keith Burridge
Journal:  J Cell Biol       Date:  2007-09-17       Impact factor: 10.539

View more
  3 in total

1.  Immunological and Functional Characterization of RhoGDI3 and Its Molecular Targets RhoG and RhoB in Human Pancreatic Cancerous and Normal Cells.

Authors:  Mercedes Piedad de León-Bautista; Maria Del Carmen Cardenas-Aguayo; Diana Casique-Aguirre; Manuel Almaraz-Salinas; Sara Parraguirre-Martinez; Angelica Olivo-Diaz; María Del Rocío Thompson-Bonilla; Miguel Vargas
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

Review 2.  Rac GTPase Signaling in Immune-Mediated Mechanisms of Atherosclerosis.

Authors:  Cadence F Lee; Rachel E Carley; Celia A Butler; Alan R Morrison
Journal:  Cells       Date:  2021-10-20       Impact factor: 6.600

3.  A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases.

Authors:  Ana Masara Binti Ahmad Mokhtar; Samrein B M Ahmed; Nicola J Darling; Matthew Harris; Helen R Mott; Darerca Owen
Journal:  Biochemistry       Date:  2021-04-29       Impact factor: 3.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.